Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF (V600E) mutant cancer cells.

Research output: Contribution to conferenceProceeding

Original languageAmerican English
StatePublished - 2013
EventThe 104st Annual Meeting of the American Association for Cancer Research - Washington D.C., USA
Duration: 06 04 201310 04 2013

Conference

ConferenceThe 104st Annual Meeting of the American Association for Cancer Research
Period06/04/1310/04/13

Cite this